{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:10:53Z","timestamp":1789726253632,"version":"4.0.1"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T00:00:00Z","timestamp":1627344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Belgian Respiratory Society"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Macrolides are widely prescribed antibiotics for many different indications. However, there are concerns about adverse effects such as ototoxicity.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To investigate whether macrolide use is associated with tinnitus and hearing loss in the general population.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Cross-sectional (n\u2009=\u20094286) and longitudinal (n\u2009=\u2009636) analyses were performed within the population-based Rotterdam Study. We investigated with multivariable logistic regression models the association between macrolides and tinnitus, and with multivariable linear regression models the association between macrolides and two different hearing thresholds (both ears, averaged over 0.25, 0.5, 1, 2, 4 and 8\u2009kHz and 2, 4 and 8\u2009kHz). Both regression models were adjusted for age, sex, systolic blood pressure, alcohol, smoking, BMI, diabetes, education level, estimated glomerular filtration rate and other ototoxic or tinnitus-generating drugs. Cumulative exposure to macrolides was categorized according to the number of dispensed DDDs and duration of action.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In the fully adjusted model, ever use of macrolides was associated with a 25% higher likelihood of prevalent tinnitus (OR\u2009=\u20091.25; 95% CI 1.07\u20131.46). This association was more prominent in participants with a cumulative dose of more than 14 DDDs and among users of intermediate- or long-acting macrolides. Macrolide use in between both assessments was associated with more than a 2-fold increased risk on incident tinnitus. No general association between macrolides and hearing loss was observed. A borderline significant higher hearing threshold in very recent users (\u22643\u2009weeks) was found.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Macrolide use was significantly associated with both prevalent and incident tinnitus. Macrolide-associated tinnitus was likely cumulative dose-dependent.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jac\/dkab232","type":"journal-article","created":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T11:07:50Z","timestamp":1624014470000},"page":"2708-2716","source":"Crossref","is-referenced-by-count":23,"title":["Macrolide-associated ototoxicity: a cross-sectional and longitudinal study to assess the association of macrolide use with tinnitus and hearing loss"],"prefix":"10.1093","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5902-917X","authenticated-orcid":false,"given":"Anna","family":"Vanoverschelde","sequence":"first","affiliation":[{"name":"Department of Bioanalysis, Pharmaceutical Care Unit, Ghent University, Ottergemsesteenweg 460, 9000, Ghent, Belgium"},{"name":"Department of Epidemiology, Erasmus Medical Centre, PO Box 2040, 3000 CA, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berthe C","family":"Oosterloo","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Erasmus Medical Centre, PO Box 2040, 3000 CA, Rotterdam, The Netherlands"},{"name":"Department of Otorhinolaryngology and Head and Neck Surgery, Erasmus Medical Centre, PO Box 2040, 3000 CA, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelly F","family":"Ly","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Erasmus Medical Centre, PO Box 2040, 3000 CA, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Arfan","family":"Ikram","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Erasmus Medical Centre, PO Box 2040, 3000 CA, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Goedegebure","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology and Head and Neck Surgery, Erasmus Medical Centre, PO Box 2040, 3000 CA, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno H","family":"Stricker","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Erasmus Medical Centre, PO Box 2040, 3000 CA, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lies","family":"Lahousse","sequence":"additional","affiliation":[{"name":"Department of Bioanalysis, Pharmaceutical Care Unit, Ghent University, Ottergemsesteenweg 460, 9000, Ghent, Belgium"},{"name":"Department of Epidemiology, Erasmus Medical Centre, PO Box 2040, 3000 CA, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,7,27]]},"reference":[{"key":"2021091709025836100_dkab232-B1","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S1473-3099(14)70780-7","article-title":"Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data","volume":"14","author":"Van Boeckel","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"2021091709025836100_dkab232-B2"},{"key":"2021091709025836100_dkab232-B3"},{"key":"2021091709025836100_dkab232-B4"},{"key":"2021091709025836100_dkab232-B5"},{"key":"2021091709025836100_dkab232-B6","doi-asserted-by":"crossref","first-page":"e2163","DOI":"10.1002\/rmv.2163","article-title":"Azithromycin in viral infections","volume":"31","author":"Oliver","year":"2021","journal-title":"Rev Med Virol"},{"key":"2021091709025836100_dkab232-B7","first-page":"vi37","article-title":"European Surveillance of Antimicrobial Consumption (ESAC): outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe (1997-2009)","volume":"66 Suppl 6","author":"Adriaenssens","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"2021091709025836100_dkab232-B8","first-page":"CD011825","article-title":"Adverse events in people taking macrolide antibiotics versus placebo for any indication","author":"Hansen","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"2021091709025836100_dkab232-B9","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/lary.26799","article-title":"Macrolide-associated sensorineural hearing loss: a systematic review","volume":"128","author":"Ikeda","year":"2018","journal-title":"Laryngoscope"},{"key":"2021091709025836100_dkab232-B10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0002-9343(92)90016-5","article-title":"Erythromycin ototoxicity: prospective assessment with serum concentrations and audiograms in a study of patients with pneumonia","volume":"92","author":"Swanson","year":"1992","journal-title":"Am J Med"},{"key":"2021091709025836100_dkab232-B11","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1001\/archinte.1993.00410070063009","article-title":"Clinically significant hearing loss in renal allograft recipients treated with intravenous erythromycin","volume":"153","author":"Vasquez","year":"1993","journal-title":"Arch Intern Med"},{"key":"2021091709025836100_dkab232-B12","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/000348940010900416","article-title":"Irreversible sensorineural hearing loss as a result of azithromycin ototoxicity. A case report","volume":"109","author":"Ress","year":"2000","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"2021091709025836100_dkab232-B13","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1136\/pgmj.2004.020412","article-title":"Irreversible sensorineural hearing loss due to clarithromycin","volume":"81","author":"Coulston","year":"2005","journal-title":"Postgrad Med J"},{"key":"2021091709025836100_dkab232-B14","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/MAO.0000000000001887","article-title":"Azithromycin and sensorineural hearing loss in adults: a retrospective cohort study","volume":"39","author":"Alrwisan","year":"2018","journal-title":"Otol Neurotol"},{"key":"2021091709025836100_dkab232-B15","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/lary.26190","article-title":"Risk of sensorineural hearing loss with macrolide antibiotics: a nested case-control study","volume":"127","author":"Etminan","year":"2017","journal-title":"Laryngoscope"},{"key":"2021091709025836100_dkab232-B16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/ijpp.12670","article-title":"Sensorineural hearing loss with macrolide antibiotics exposure: a meta-analysis of the association","volume":"29","author":"Alsowaida","year":"2021","journal-title":"Int J Pharm Pract"},{"key":"2021091709025836100_dkab232-B17","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1258\/002221503322683984","article-title":"Tinnitus due to clarithromycin","volume":"117","author":"Uzun","year":"2003","journal-title":"J Laryngol Otol"},{"key":"2021091709025836100_dkab232-B18","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3109\/01050398609045952","article-title":"Irreversible ototoxic effect of erythromycin","volume":"15","author":"Levin","year":"1986","journal-title":"Scand Audiol"},{"key":"2021091709025836100_dkab232-B19","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1164\/rccm.200801-145OC","article-title":"Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations","volume":"178","author":"Seemungal","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"2021091709025836100_dkab232-B20","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s10654-020-00640-5","article-title":"Objectives, design and main findings until 2020 from the Rotterdam Study","volume":"35","author":"Ikram","year":"2020","journal-title":"Eur J Epidemiol"},{"key":"2021091709025836100_dkab232-B21","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000492203","article-title":"Progression of hearing loss in the aging population: repeated auditory measurements in the Rotterdam study","volume":"23","author":"Rigters","year":"2018","journal-title":"Audiol Neurootol"},{"key":"2021091709025836100_dkab232-B22","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1177\/0194599820957296","article-title":"Prevalence of tinnitus in an aging population and its relation to age and hearing loss","volume":"164","author":"Oosterloo","year":"2021","journal-title":"Otolaryngol Head Neck Surg"},{"key":"2021091709025836100_dkab232-B23"},{"key":"2021091709025836100_dkab232-B24","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1288\/00005537-196009000-00001","article-title":"The principles and practice of bone conduction audiometry: a review of the present position","volume":"70","author":"Hood","year":"1960","journal-title":"Laryngoscope"},{"key":"2021091709025836100_dkab232-B25","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/eurpub\/ckr176","article-title":"Global and regional hearing impairment prevalence: an analysis of 42 studies in 29 countries","volume":"23","author":"Stevens","year":"2013","journal-title":"Eur J Public Health"},{"key":"2021091709025836100_dkab232-B26","year":"1976"},{"key":"2021091709025836100_dkab232-B27","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s10654-017-0295-2","article-title":"Adherence to the 2015 Dutch dietary guidelines and risk of non-communicable diseases and mortality in the Rotterdam Study","volume":"32","author":"Voortman","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"2021091709025836100_dkab232-B28","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S2213-8587(15)00362-9","article-title":"Lifetime risk of developing impaired glucose metabolism and eventual progression from prediabetes to type 2 diabetes: a prospective cohort study","volume":"4","author":"Ligthart","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2021091709025836100_dkab232-B29","first-page":"7946","article-title":"Drugs inducing hearing loss, tinnitus, dizziness and vertigo: an updated guide","volume":"24","author":"Altissimi","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2021091709025836100_dkab232-B30","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/cpt.603","article-title":"Drug-induced ototoxicity: mechanisms, pharmacogenetics, and protective strategies","volume":"101","author":"Lanvers-Kaminsky","year":"2017","journal-title":"Clin Pharmacol Ther"},{"key":"2021091709025836100_dkab232-B31","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000448348","article-title":"Contributing determinants to hearing loss in elderly men and women: results from the population-based Rotterdam Study","volume":"21 Suppl 1","author":"Rigters","year":"2016","journal-title":"Audiol Neurootol"},{"key":"2021091709025836100_dkab232-B32","first-page":"101","volume-title":"Ototoxicity","author":"Scott","year":"2004"},{"key":"2021091709025836100_dkab232-B33","doi-asserted-by":"crossref","first-page":"e0183192","DOI":"10.1371\/journal.pone.0183192","article-title":"Increased risk of tinnitus in patients with chronic kidney disease: a nationwide, population-based cohort study","volume":"12","author":"Shih","year":"2017","journal-title":"PLoS One"},{"key":"2021091709025836100_dkab232-B34","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2018.00866","article-title":"Pathophysiology of subjective tinnitus: triggers and maintenance","volume":"12","author":"Haider","year":"2018","journal-title":"Front Neurosci"},{"key":"2021091709025836100_dkab232-B35","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1258\/0022215011908676","article-title":"Reversible ototoxic effect of azithromycin and clarithromycin on transiently evoked otoacoustic emissions in guinea pigs","volume":"115","author":"Uzun","year":"2001","journal-title":"J Laryngol Otol"},{"key":"2021091709025836100_dkab232-B36","first-page":"186","article-title":"Ototoxicity of erythromycin in man: electrophysiologic approach","volume":"14","author":"Sacristan","year":"1993","journal-title":"Am J Otol"},{"key":"2021091709025836100_dkab232-B37","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/00129492-200307000-00029","article-title":"Erythromycin ototoxicity","volume":"24","author":"McGhan","year":"2003","journal-title":"Otol Neurotol"},{"key":"2021091709025836100_dkab232-B38","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.neuroscience.2019.01.027","article-title":"Tinnitus: does gain explain?","volume":"407","author":"Sedley","year":"2019","journal-title":"Neuroscience"},{"key":"2021091709025836100_dkab232-B39","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s40261-017-0498-z","article-title":"Neuropsychiatric effects of antimicrobial agents","volume":"37","author":"Zareifopoulos","year":"2017","journal-title":"Clin Drug Investig"},{"key":"2021091709025836100_dkab232-B40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.heares.2009.10.008","article-title":"Education, occupation, noise exposure history and the 10-yr cumulative incidence of hearing impairment in older adults","volume":"264","author":"Cruickshanks","year":"2010","journal-title":"Hear Res"},{"key":"2021091709025836100_dkab232-B41","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1007\/s00405-013-2675-x","article-title":"Sensorineural hearing loss: a complication of acute otitis media in adults","volume":"271","author":"Park","year":"2014","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"2021091709025836100_dkab232-B42"},{"key":"2021091709025836100_dkab232-B43","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.heares.2016.05.009","article-title":"A systematic review of the reporting of tinnitus prevalence and severity","volume":"337","author":"McCormack","year":"2016","journal-title":"Hear Res"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/76\/10\/2708\/40394595\/dkab232.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/76\/10\/2708\/40394595\/dkab232.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T09:26:06Z","timestamp":1631870766000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/76\/10\/2708\/6328751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,27]]},"references-count":43,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,7,27]]},"published-print":{"date-parts":[[2021,9,15]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkab232","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,10,1]]},"published":{"date-parts":[[2021,7,27]]}}}